Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article matching "Methionine adenosyltransferase I/III deficiency"

ResearchRSSToday

Toxic protein clumps damage brain blood vessels in Parkinson’s: Study

Scientists discovered that in Parkinson's disease, clumps of a toxic protein called alpha-synuclein damage not just brain cells but also the tiny blood vessels that supply the brain. These two types of damage likely work together to make the disease worse over time. This finding helps explain why Parkinson's affects the brain in multiple ways.

WHY IT MATTERSUnderstanding that blood vessel damage contributes to Parkinson's progression could lead to new treatments that protect blood vessels, potentially slowing disease advancement beyond current approaches that only target brain cell damage.
Good to knowParkinson's diseaseRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases